Success Metrics

Clinical Success Rate
85.7%

Based on 12 completed trials

Completion Rate
86%(12/14)
Active Trials
3(16%)
Results Posted
58%(7 trials)
Terminated
2(11%)

Phase Distribution

Ph phase_1
1
5%
Ph phase_2
7
37%
Ph not_applicable
2
11%
Ph phase_4
6
32%
Ph phase_3
3
16%

Phase Distribution

1

Early Stage

7

Mid Stage

9

Late Stage

Phase Distribution19 total trials
Phase 1Safety & dosage
1(5.3%)
Phase 2Efficacy & side effects
7(36.8%)
Phase 3Large-scale testing
3(15.8%)
Phase 4Post-market surveillance
6(31.6%)
N/ANon-phased studies
2(10.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

12 of 14 finished

Non-Completion Rate

14.3%

2 ended early

Currently Active

3

trials recruiting

Total Trials

19

all time

Status Distribution
Active(3)
Completed(12)
Terminated(2)
Other(2)

Detailed Status

Completed12
Recruiting3
Terminated2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
19
Active
3
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.3%)
Phase 27 (36.8%)
Phase 33 (15.8%)
Phase 46 (31.6%)
N/A2 (10.5%)

Trials by Status

terminated211%
recruiting316%
unknown211%
completed1263%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT06865430Not Applicable

Management of Dysuria and Irritative Symptoms After HoLEP: a Prospective Study Evaluating the Efficacy of Alpha-Blocker Therapy

Recruiting
NCT06867315Not Applicable

The Safety and Effectiveness of Steep Pulse Therapy System for the Ablation of Benign Prostatic Hyperplasia

Recruiting
NCT02757768Phase 4

A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)

Completed
NCT04994431Phase 4

Post-Operative Urinary Retention (POUR) in Thoracic Surgery Patients Receiving Prophylactic Tamsulosin

Terminated
NCT06262048Phase 2

Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial

Recruiting
NCT01568918Phase 3

Use of Tamsulosin to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery

Terminated
NCT05890235Phase 4

Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Completed
NCT04987892Phase 4

Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for BPH

Unknown
NCT04159077Phase 3

REduction of Post-Operative Urinary Retention With Tamsulosin Versus Placebo (REPOURT- P) Trial

Unknown
NCT04552431Phase 2

Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and Tamsulosin

Completed
NCT02573311Phase 3

Actual Use Study of Tamsulosin in Men

Completed
NCT00223717Phase 1

Treatment of Supine Hypertension in Autonomic Failure

Completed
NCT00340704Phase 2

PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder

Completed
NCT00796614Phase 2

Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder

Completed
NCT02244242Phase 4

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

Completed
NCT02244281Phase 2

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

Completed
NCT00510406Phase 2

A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH

Completed
NCT00507455Phase 2

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

Completed
NCT00771394Phase 4

Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia

Completed

All 19 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
19